Octapharma is a global healthcare company headquartered in Lachen, Switzerland and Paramus, New Jersey, USA. Our products are available in 118 countries and reach hundreds of thousands of patients every year. We focus on three therapeutic areas: hematology, immunotherapy and critical care. Octapharma hematology factor therapies replace the missing coagulation factor in patients with bleeding disorders to effectively control bleeding. Hemophilia A and von Willebrand disease patients alike take confidence in our disease-targeted medications, our production expertise with the highest standards for purity, and our years of commitment to improving the lives of those in the bleeding disorders community. We are proud to support the Central Ohio Chapter of NHF and participate in this years Unite Walk!